BTIG Maintains Buy on Solventum, Raises Price Target to $95

سولفنتوم

Solventum Corporation

SOLV

0.00

BTIG analyst Ryan Zimmerman maintains Solventum (NYSE: SOLV) with a Buy and raises the price target from $91 to $95.